当前位置: X-MOL 学术npj Digit. Med. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
ACTsmart - development and feasibility of digital Acceptance and Commitment Therapy for adults with chronic pain.
npj Digital Medicine ( IF 12.4 ) Pub Date : 2020-02-13 , DOI: 10.1038/s41746-020-0228-4
Charlotte Gentili 1, 2 , Vendela Zetterqvist 1, 2, 3 , Jenny Rickardsson 1, 2 , Linda Holmström 1, 2, 4 , Laura E Simons 5 , Rikard K Wicksell 1, 2
Affiliation  

Accessibility of evidence-based behavioral health interventions is one of the main challenges in health care and effective treatment approaches are not always available for patients that would benefit from them. Digitization has dramatically changed the health care landscape. Although mHealth has shown promise in addressing issues of accessibility and reach, there is vast room for improvements. The integration of technical innovations and theory driven development is a key concern. Digital solutions developed by industry alone often lack a clear theoretical framework and the solutions are not properly evaluated to meet the standards of scientifically proven efficacy. On the other hand, mHealth interventions developed in academia may be theory driven but lack user friendliness and are commonly technically outdated by the time they are implemented in regular care, if they ever are. In an ongoing project aimed at scientific innovation, the mHealth Agile Development and Evaluation Lifecycle was used to combine strengths from both industry and academia in the development of ACTsmart - a smartphone-based Acceptance and Commitment Therapy treatment for adult chronic pain patients. The present study describes the early development of ACTsmart, in the process of moving the product from alpha testing to a clinical trial ready solution.

中文翻译:

ACTsmart - 针对成人慢性疼痛的数字接受和承诺疗法的开发和可行性。

基于证据的行为健康干预措施的可及性是医疗保健领域的主要挑战之一,而患者并不总能获得有效的治疗方法并从中受益。数字化极大地改变了医疗保健格局。尽管移动医疗在解决可及性和覆盖范围问题方面表现出了希望,但仍有巨大的改进空间。技术创新与理论驱动发展的结合是一个关键问题。仅由行业开发的数字解决方案通常缺乏清晰的理论框架,并且解决方案没有经过适当的评估以满足科学证明的功效标准。另一方面,学术界开发的移动医疗干预措施可能是理论驱动的,但缺乏用户友好性,并且在常规护理中实施时(如果有的话)在技术上通常已经过时。在一个正在进行的旨在科学创新的项目中,mHealth 敏捷开发和评估生命周期被用来结合行业和学术界的优势来开发 ACTsmart——一种针对成人慢性疼痛患者的基于智能手机的接受和承诺疗法。本研究描述了 ACTsmart 的早期开发,即该产品从 alpha 测试转向临床试验就绪解决方案的过程。
更新日期:2020-02-13
down
wechat
bug